Lived experiences of female patients aged 15-49 years undergoing treatment for multi-drug resistant tuberculosis (MDR-TB) in Lira Regional Referral Hospital, Uganda
Abstract: Multidrug-resistant tuberculosis (MDR-TB) is a major public health hazard on a global scale. It is a kind of tuberculosis (TB) infection produced by bacteria resistant to at least two of the most effective first-line anti-tuberculosis (anti-TB) drugs: isoniazid and rifampicin. In numerous...
Main Authors: | Kizito Omona, Christopher Ogwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Cogent Public Health |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/27707571.2023.2292892 |
Similar Items
-
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
by: Betty R. Mchaki, et al.
Published: (2023-02-01) -
Drug rash with eosinophilia and systemic symptoms syndrome due to anti-TB medication
by: Dharmesh H Kaswala
Published: (2013-01-01) -
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
by: Jun Chen, et al.
Published: (2017-04-01) -
Line-probe assay and molecular typing reveal a potential drug resistant clone of Mycobacterium tuberculosis in Ethiopia
by: Shiferaw Bekele, et al.
Published: (2018-12-01) -
PREVALENCE AND RISK FACTORS OF MULTI DRUG RESISTANT TUBERCULOSISAMONG REFUGEES IN THE RESETTLEMENTCAMPS OF ADJUMANI, MOYO AND YUMBE DISTRICTSWEST NILE REGION
by: Laurent Nshizirungu, et al.
Published: (2020-12-01)